Home / Education / Mescaline

Mescaline

Peyote, San Pedro, and a sacrament under pressure. A forthcoming title in the Metanoia Press library.

Metanoia Press · In preparation

A long human history, and an ethics question that comes first

Mescaline is the psychedelic in the cactus. The oldest physical evidence of peyote use the page found comes from Texas rock shelters and is several thousand years old, though its dating is contested. It is also the one where the science cannot be told apart from the ethics: peyote is a plant under pressure, sacred to Native American communities, and protected by hard-won religious rights. Our forthcoming book treats that not as a caveat but as the center of the story.

This book is being written.

What the Book Will Cover

One molecule, two cacti, a live debate

I

The chemistry

Mescaline as a phenethylamine, a different chemical class from the tryptamines, reaching the same 5-HT2A doorway by another road.

II

Two cacti

Peyote of the southern deserts and San Pedro of the Andes, and why the difference between them matters.

III

The tradition

Ancient ceremonial use and the Native American Church, living practice, not history.

+

Conservation & sovereignty

Why the whole-versus-synthetic debate here is political, not just pharmacological, and where we stand.

The science, and the ethics that come with it

Mescaline is a phenethylamine and an agonist at the 5-HT2A and 5-HT2C receptors, producing effects in the same family as LSD and psilocybin but with a slower, longer arc. It was studied in Western psychiatry in the early 20th century before LSD eclipsed it. The modern human evidence is thin. It is mostly observational surveys reporting wellbeing benefits, plus two randomised trials at one hospital in Basel, in about fifty healthy people. The first compared mescaline with LSD and psilocybin and found comparable acute effects under the study's conditions. Those studies measured acute effects, not lasting benefit, so the benefit claims remain a long way from controlled proof.

Here the whole-versus-isolated question we ask across the family becomes an ethical one. The IUCN Red List classifies peyote (Lophophora williamsii) as Vulnerable, with a decreasing population. Native American Church organizations also describe it as under pressure, and sources differ on the causes. In the United States peyote and mescaline are Schedule I. A federal regulation exempts the nondrug use of peyote in bona fide religious ceremonies of the Native American Church, and a 1994 federal statute makes lawful the use, possession or transportation of peyote by an Indian for bona fide traditional ceremonial purposes in connection with the practice of a traditional Indian religion. Indigenous organizations have stated positions of their own. The Indigenous Peyote Conservation Initiative, a United States group, opposes legalization or decriminalization of peyote beyond the religious use protected by the 1994 statute, and says that extraction of mescaline from natural peyote should be prevented. Its board has no political position on synthetic mescaline. These statements concern peyote as a plant, a matter of sovereignty over a sacred plant, and they do not speak for all Indigenous people. This describes the law. It is not legal advice and grants no permission.

Where Metanoia stands. We will not promote peyote. It is a slow-growing plant under pressure that is sacred to Indigenous communities, and we respect their rights over their sacred medicine. Reciprocity and credit, never appropriation. Read our full ethics position

Reliability: receptor pharmacology is well established (strong). Human benefit data is observational (limited). Full sources will accompany the finished book.

Read the published book   Ethics & legality   See the whole family